My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 2 results for

GO
Search Filters: New Hampshire cancel Population Health and Prevention cancel New York cancel Social and Behavioral Health cancel Massachusetts cancel Florida cancel New Jersey cancel Illinois cancel

State/Territorial Policy Considerations for Preventing Adverse Childhood Experiences

Report,
Policy,
State Health Policy,
Population Health and Prevention,
Women, Infant, and Family Health,
ACEs,
Health Equity,
At-Risk Populations,
Social Determinants of Health,
Social and Behavioral Health,
Injury and Violence Prevention,
Alaska,
Arizona,
Arkansas,
California,
Colorado,
Connecticut,
Delaware,
Florida,
Hawaii,
Idaho,
Illinois,
Maine,
Maryland,
Massachusetts,
Michigan,
Minnesota,
New Hampshire,
New Jersey,
New Mexico,
New York,
North Dakota,
Ohio,
Oregon,
Rhode Island,
Tennessee,
Texas,
Vermont,
Virginia,
Washington,
Washington, D.C.,
Youth Mental Health,
LGBTQ+,
Firearm Injury and Violence Prevention

ASTHO staff identified a range of evidence-supported policies considered by state legislatures that could prevent ACEs. This report synthesizes these research and policy proposals and is intended for public health practitioners and ...

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...